The 3rd Griffith University ECR Cross Institute Symposium will be held on Friday the 4th of November, 2022 at the
G40: Lecture Theatre 1, Griffith University Gold Coast Campus. The event aims to bring together early career researchers (PhD and up to 10 year post PhD) to network and share research and ideas.
The 3rd Griffith University ECR Cross Institute Symposium brings together ECR researchers from four institutes at Griffith University, Queensland: Menzies Health Institute, Griffith Institute for Drug Discovery, Glycomic, and Queensland Micro and Nanotechnology Centre.
Dr Andrew Rayfield is a Research Fellow and the Research Manager for the Clem Jones Centre for Neurobiology and Stem Cell Research at Griffith University, part of both MHIQ and GRIDD. Dr Rayfield received his PhD degree from the University of Queensland, where he investigated scaffold proteins in the mammalian brain, in particular glial c
Dr Andrew Rayfield is a Research Fellow and the Research Manager for the Clem Jones Centre for Neurobiology and Stem Cell Research at Griffith University, part of both MHIQ and GRIDD. Dr Rayfield received his PhD degree from the University of Queensland, where he investigated scaffold proteins in the mammalian brain, in particular glial cells. Andrew has a keen interest in glial cell biology, which is key to the Clem Jones Centre's mission to create therapies for the injured nervous system. Their main project is to create a therapy for spinal cord injury.
Dr Belinda De Villiers is currently pursuing her first postdoctoral fellowship at the Institute for Glycomics. Here she is investigating the role of glycans in HIV biology as well as developing a PC2 safe SARS-CoV-2 surrogate VLP system. Belinda currently holds an AQIRF fellowship for her work contributing towards a solution for the curre
Dr Belinda De Villiers is currently pursuing her first postdoctoral fellowship at the Institute for Glycomics. Here she is investigating the role of glycans in HIV biology as well as developing a PC2 safe SARS-CoV-2 surrogate VLP system. Belinda currently holds an AQIRF fellowship for her work contributing towards a solution for the current SARS-CoV-2 pandemic. She also holds an ACH2 grant to develop a diagnostic tool for HTLV-1 and lymphocytosis, aimed at patients in the remote Australian outback.
Dr Miaomiao Liu obtained dual PhD degrees in 2017 from Griffith University and the University of Chinese Academic of Sciences. Her current research interests involve the target identification using native mass spectrometry, identification of bioactive natural products using a pheno-target approach and NMR fingerprints. Dr Liu has also mad
Dr Miaomiao Liu obtained dual PhD degrees in 2017 from Griffith University and the University of Chinese Academic of Sciences. Her current research interests involve the target identification using native mass spectrometry, identification of bioactive natural products using a pheno-target approach and NMR fingerprints. Dr Liu has also made great contributions in the field of natural product chemistry specialising in the microbial metabolomics, biotransformation, natural product isolation.
Dr Xiang Liu is working as a post doctoral research fellow in Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland. His research interests focus on the interplay between virus infection and the host innate immune response and the repercussions on human viral disease pathology.
Dr Greg Tram was awarded a PhD from the Institute for Glycomics studying biofilm formation and chemotaxis in the foodborne pathogen Campylobacter jejuni under Victoria Korolik and Chris Day. Greg then continued as a postdoctoral researcher in the Jennings and Atack groups investigating phase variation, host-pathogen interactions and study
Dr Greg Tram was awarded a PhD from the Institute for Glycomics studying biofilm formation and chemotaxis in the foodborne pathogen Campylobacter jejuni under Victoria Korolik and Chris Day. Greg then continued as a postdoctoral researcher in the Jennings and Atack groups investigating phase variation, host-pathogen interactions and studying the role carbohydrates play in pathogenesis across a range of bacterial species.
Dr Ronak Reshamwala is a research fellow with the Clem Jones Centre for Neurobiology and Stem Cell Research at Menzies Health Institute Queensland, Griffith University, Australia. He is a medical doctor by training and has received his PhD in 2020 from Griffith University. Dr Reshamwala's main research interests include translational rese
Dr Ronak Reshamwala is a research fellow with the Clem Jones Centre for Neurobiology and Stem Cell Research at Menzies Health Institute Queensland, Griffith University, Australia. He is a medical doctor by training and has received his PhD in 2020 from Griffith University. Dr Reshamwala's main research interests include translational research, regenerative neurology, spinal cord injury, neurodegeneration, and pain perception. His PhD work focused on developing novel approaches or transplantation of 3D cellular constructs in the injured spinal cord to induce structural and functional repairs. He is currently working on developing better translatable and robust surgical approaches as well as behavioural tests for treating and assessing spinal cord injuries.
Dr Jun Zhang is currently an ARC DECRA fellow at Queensland Micro- and Nanotechnology Centre, Griffith University, Australia. His research exploits passive fluid dynamics and rheology, active magnetic and electrical force fields and combinations for manipulation and separation of micro/nanoparticles in microfluidic platform and explores their biomedical application such as liquid biopsy.
Dr Gayathri Thillaiyampalam is working as a research fellow in cancer immunology and drug discovery at Griffith Institute for Drug Discovery. Her current research interests involve investigating the role of non-coding RNAs in the activation of innate immune system primarily natural killer cells against blood cancers. She has a keen intere
Dr Gayathri Thillaiyampalam is working as a research fellow in cancer immunology and drug discovery at Griffith Institute for Drug Discovery. Her current research interests involve investigating the role of non-coding RNAs in the activation of innate immune system primarily natural killer cells against blood cancers. She has a keen interest in exploiting Bioinformatics techniques and tools for drug discovery.
Dr Chin Hong Ooi is an ARC DECRA fellow. He received his PhD in 2017 at the Queensland Micro and Nanotechnology Centre (QMNC) Griffith University, with a background in Physics and Mechanical Engineering. His research interests include non-wetting droplet (liquid marble) manipulation and biological applications; digital microfluidics; 3D d
Dr Chin Hong Ooi is an ARC DECRA fellow. He received his PhD in 2017 at the Queensland Micro and Nanotechnology Centre (QMNC) Griffith University, with a background in Physics and Mechanical Engineering. His research interests include non-wetting droplet (liquid marble) manipulation and biological applications; digital microfluidics; 3D design and fabrication of microfluidic devices and colloid and interface physics. Dr. Ooi's team works on exploring various aspects of non-wetting droplet such as fundamental physics, engineering, and downstream applications. Dr. Ooi teaches the Electromechanics course at the Nathan campus.
Griffith University ECR Cross-Institute Symposium
Copyright © 2022 Griffith University ECR Cross-Institute Symposium - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.